Search
News
Important Only
Other
Rocket Pharmaceuticals Provides Update On Phase 2 Clinical Trial Of Rp-A501 For Danon Disease
May 27 (Reuters) - Rocket Pharmaceuticals Inc RCKT.O:ROCKET PHARMACEUTICALS PROVIDES UPDATE ON PHASE 2 CLINICAL TRIAL OF RP-A501 FOR DANON DISEASEROCKET PHARMACEUTICALS INC - IN ACTIVE DIALOGUE WITH FDA AFTER SAE IN RP-A501 TRIALROCKET PHARMACEUTICALS INC - FDA PLACES CLINICAL HOLD ON RP-A501 TRIAL ...Reuters
Tue, May 27
Other
Rein Therapeutics Announces First Patient Dosed In Renew Phase 2 Trial Of Lti-03 In Patients With Ipf
May 27 (Reuters) - REIN THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN RENEW PHASE 2 TRIAL OF LTI-03 IN PATIENTS WITH IPFREIN THERAPEUTICS INC: TOPLINE INTERIM DATA FROM RENEW IS EXPECTED IN FIRST HALF OF 2026Reuters
Tue, May 27
Other
Imaflex Q1 EPS CAD 0.01
May 27 (Reuters) - Imaflex Inc IFX.V:IMAFLEX Q1 EPS CAD 0.01IMAFLEX Q1 EBITDA CAD 2.123 MILLIONIMAFLEX Q1 NET INCOME CAD 264 THOUSANDIMAFLEX Q1 REVENUE CAD 28.923 MILLIONIMAFLEX Q1 GROSS PROFIT CAD 4.725 MILLIONIMAFLEX Q1 BASIC EPS CAD 0.01IMAFLEX Q1 GROSS MARGIN 16.3%Reuters
Tue, May 27
Other
REFILE-ANALYSIS-US climate pullback threatens planned debt-for-nature deals
US Development Finance Corporation support in questionAngola, Zambia swaps among those impacted, sources say Angola says DFC more open to a development-swap dealBy Marc Jones and Virginia Furness LONDON, May 22 (Reuters) - Billions of dollars of debt deals aimed at protecting vital ecosystems fro...Reuters
Tue, May 27
Other
FACTBOX-Foreign companies eye US expansion to lessen fallout from tariffs
May 27 (Reuters) - Some non-U.S. companies have said they are looking at expanding their presence or setting up shop in the United States to mitigate the impact of President Donald Trump's tariffs.Below are some of the plans flagged by those companies.BARRY CALLEBAUT BARN.SThe chocolate maker is...Reuters
Tue, May 27
Other
Ituran Announces New OEM Agreement With Stellantis In South America
May 27 (Reuters) - Ituran Location and Control Ltd ITRN.O:ITURAN ANNOUNCES NEW OEM AGREEMENT WITH STELLANTIS IN SOUTH AMERICAITURAN LOCATION AND CONTROL LTD - CONTRACT COVERS MULTIPLE COUNTRIES IN SOUTH AMERICA FOR MULTI-YEAR PERIODReuters
Tue, May 27
Other
Brainstorm Secures Key Manufacturing Partnership With Minaris For Upcoming Nurown Phase 3B Als Clinical Trials
May 27 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.O:BRAINSTORM SECURES KEY MANUFACTURING PARTNERSHIP WITH MINARIS FOR UPCOMING NUROWN® PHASE 3B ALS CLINICAL TRIALSReuters
Tue, May 27
Other
Ocugen Announces Rare Pediatric Disease Designation Granted For Ocu410st—Modifier Gene Therapy For The Treatment Of Stargardt Disease
May 27 (Reuters) - Ocugen Inc OCGN.O:OCUGEN ANNOUNCES RARE PEDIATRIC DISEASE DESIGNATION GRANTED FOR OCU410ST—MODIFIER GENE THERAPY FOR THE TREATMENT OF STARGARDT DISEASEOCUGEN INC: PLANS TO INITIATE PHASE 2/3 PIVOTAL CONFIRMATORY TRIAL IN FEW WEEKS WITH TARGET BLA IN 2027Reuters
Tue, May 27
Other
Gilat Receives Over $25 Million In Orders For Its Multi-Orbit Satellite Solutions
May 27 (Reuters) - Gilat Satellite Networks Ltd GILT.TA:GILAT RECEIVES OVER $25 MILLION IN ORDERS FOR ITS MULTI-ORBIT SATELLITE SOLUTIONSGILAT SATELLITE NETWORKS LTD - DELIVERIES SCHEDULED THROUGHOUT 2025 AND 2026Reuters
Tue, May 27
Other
Circle Internet Group - IPO Price Expected Between $24.00 And $26.00 Per Share - SEC Filing
May 27 (Reuters) - CIRCLE INTERNET GROUP INC - IPO PRICE EXPECTED BETWEEN $24.00 AND $26.00 PER SHARE - SEC FILINGCIRCLE INTERNET GROUP INC - FILES FOR IPO OF 24 MILLION CLASS A COMMON STOCK - SEC FILINGSource text: [ID:n0001193125-25-126208]Further company coverage: [ ]Reuters
Tue, May 27
Featured Tools
Top News
Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October
Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock
IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?
What company Is ASML? Between ASML and AMD, Which Is a Better Investment?
Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market
Market Movers
Tradingkey
